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Objectives The purpose of this study was to define the incidence, mechanisms, and management, including catheter ablation, of
supraventricular tachycardia (SVT) in a large series of patients after orthotopic heart transplantation (OHT).
Background Supraventricular arrhythmias are frequently encountered after OHT, but their characteristics in this population
have not been well established.
Methods We analyzed the incidence, clinical course, and management of SVTs in a cohort of 729 adult patients who un-
derwent OHT. Furthermore, the mechanisms of arrhythmias among the patients referred for electrophysiological
study (EPS) and ablation were also characterized.
Results The most common arrhythmia was atrial flutter, which occurred in 9% of this cohort. Persistent or paroxysmal
atrial fibrillation occurred in 7%, the majority (57%) in the perioperative period. Persistent or paroxysmal atrial
fibrillation was observed in OHT patients, beyond the post-operative period, only in the presence of rejection or
transplant vasculopathy. Other persistent or paroxysmal SVTs were seen in 47 stable OHT patients (7%). Of
these, 24 patients (4%) underwent EPS. Accessory and dual atrioventricular nodal pathways in the donor heart
caused SVT in 3 patients. Macro-reentrant atrial tachycardia was seen in 7 patients, and isthmus-dependent
atrial flutter occurred in 14 patients.
Conclusions The majority of SVTs in stable OHT patients can be attributed to macro-reentrant tachycardias (flutter and scar
reentry). Catheter ablation is effective in management of these SVTs. Atrial fibrillation was never encountered in
stable patients in our series, and its occurrence should prompt an evaluation for acute rejection and/or
vasculopathy. (J Am Coll Cardiol 2008;51:2241–9) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.02.065r
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phe incidence, clinical course, and management of supraven-
ricular tachycardias (SVTs) in orthotopic heart transplant
OHT) patients have not been well characterized. Trans-
lanted hearts provide a unique model to study the man-
gement of these arrhythmias, because of the relative auto-
omic denervation and the pro-arrhythmic characteristics of
urgical scars. Previous studies have reported atrioventric-
lar nodal (AVNRT) and atrioventricular reentrant
achycardias (AVRT) in transplanted patients due to
re-existing accessory pathways and dual atrioventricular
odal physiology in the donor hearts (1–5). Macro-
rom the *UCLA Cardiac Arrhythmia Center and the †UCLA Heart Transplant
rogram, Division of Cardiology, Department of Medicine, David Geffen School of
edicine at UCLA, Los Angeles, California. This work was supported by grants
rom the American Heart Association, National Affiliate (grant #0430287N), and the
ational Heart, Lung, and Blood Institute, R01HL084261, to Dr. Shivkumar. This
eport was presented in part at the American Heart Association Annual Scientific
essions, November 9–12, 2003, Orlando, Florida.c
Manuscript received November 19, 2007; revised manuscript received January 29,
008, accepted February 5, 2008.eentrant atrial tachycardias (ATs) from pro-arrhythmic
ubstrates originating at surgical anastomotic sites have
lso been reported (6 –9).
Atrial flutter (AFL) and atrial fibrillation (AF) are
nown to occur in patients with acute rejection, trans-
lant vasculopathy, or in the immediate post-operative
eriod (10 –13). Whereas AFL has also been described in
table transplant patients (14 –18), the mechanisms and
ccurrence of AF in patients without the aforementioned
onditions are not clear. In fact, in 1 study, heart
ransplantation was an independent predictor of freedom
rom post-operative AF when compared with patients
ith other cardiac surgeries (19). Nevertheless, a rare case
f AF in the absence of rejection or vasculopathy has
een described (20).
The purpose of this study was to quantify the incidence
f AF and AFL, to define the mechanisms of SVT in
ost-transplant patients, and to evaluate the role of
atheter ablation.
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Study cohort. A total of 729
patients who underwent OHT
between January 30, 1994, and
January 1, 2006, at our center
were screened. Retrospective re-
view of patient data was ap-
proved by our Institutional Re-
view Board. These patients were
divided into 3 groups. The first
group included patients with be-
nign atrial premature complexes
or transient SVT that resolved
without intervention. The second
included those with persistent or
paroxysmal SVT occurring during
the immediate post-operative period
or concurrent with acute rejection or
transplant vasculopathy, as docu-
mented by symptoms, right ventric-
ular endomyocardial biopsy, echo-
cardiography, and right and left
heart catheterization. The third
group, defined as stable OHT
patients, included those with re-
current persistent or paroxysmal
SVT without clinical signs or
symptoms of rejection or severe
vasculopathy, defined as at least 1
oronary artery with 70% stenosis. The second and third
roups were the primary focus of this study, and the third
roup served as the population in whom the underlying
echanism of their arrhythmia was confirmed via electro-
hysiological study (EPS). Patients with AF and AFL had
iopsies performed to rule out rejection. All patients re-
eived triple-drug immunosuppression therapy with sys-
emic steroids, cyclosporine or tacrolimus, and mycopheno-
ate mofetil or rapamycin. Patients who died in the
mmediate post-operative period were excluded.
nti-arrhythmic therapy. All patients with confirmed per-
istent or paroxysmal SVT were initially treated with car-
ioversion and antiarrhythmic drugs, including beta-
lockers, sotalol, or amiodarone. Of these patients, 24 had
ersistent drug-resistant SVTs; they were referred for EPS
nd radiofrequency catheter ablation and therefore had the
nderlying mechanism of their arrhythmias identified.
F and AFL in OHT patients. Because AF was not seen
n any patient with SVT referred for EPS and AFL was the
ost common arrhythmia initially identified, a detailed
hart review of all 729 patients transplanted between Janu-
ry 30, 1994, and January 1, 2006, was performed to
uantify the incidence of these arrhythmias. Patients who
ied in the immediate post-operative period and those 18
ears of age were excluded. For the remaining 657 patients,
Abbreviations
and Acronyms
AF  atrial fibrillation
AFL  atrial flutter
AT  macro-reentrant atrial
tachycardia
AVNRT  atrioventricular
nodal reentrant tachycardia
AVRT  atrioventricular
reentrant tachycardia
EPS  electrophysiological
study
HRV  heart rate variability
OHT  orthotopic heart
transplant
RFA  radiofrequency
ablation
RMSSD  root-mean-square
of successive normal sinus
RR interval difference
SDANN  standard
deviation of the averaged
normal sinus RR intervals
for all 5-min segments
SDNN  standard deviation
of all normal sinus RR
intervals over 24 h
SVT  supraventricular
tachycardiall clinic notes, electrocardiograms, echocardiograms, car- viac catheterization reports, stress tests, and Holter moni-
ors were carefully reviewed for evidence of AF as well as
FL. Atrial fibrillation was defined with the American
ollege of Cardiology/American Heart Association criteria
21).
eart rate variability (HRV) analysis. To better delineate
he mechanism potentially underlying paroxysmal or persis-
ent AF in stable OHT patients, a retrospective review of
ransplant patients with HRV data available on 24-h Holter
onitoring was performed. Patients with Holter monitors
anifesting significant supraventricular or ventricular ar-
hythmias were excluded. Sixteen Holter monitors re-
ained, and these were analyzed for HRV parameters,
pecifically standard deviation of all normal sinus RR
ntervals over 24 h (SDNN), standard deviation of the
veraged normal sinus RR intervals for all 5-min segments
SDANN), SDNN index, and root-mean-square of succes-
ive normal sinus RR interval difference (RMSSD), and
ompared with age- and gender-matched references previ-
usly standardized in published reports.
PS. Informed consent was obtained from all patients to
ndergo an EPS and possible radiofrequency ablation (RFA).
ultipolar mapping catheters were inserted through femoral
eins. Endocardial electroanatomic (CARTO, Biosense-
ebster, Diamond Bar, California) or NavX (St. Jude
edical, Minnetonka, Minnesota) and entrainment map-
ing were performed during EPS. Scar was defined as
yocardial regions with local electrograms 0.05 mV
nd/or regions where electrical capture could not be dem-
nstrated. Viable muscle was defined as regions with local
lectrograms 0.05 mV. Areas of native myocardium were
pecially tagged as gray zones on the electroanatomic map.
he presence of macro-reentrant tachycardia was estab-
ished by standard criteria that included: induction by
acing, pace-termination, entrainment, and noninducibility
fter ablation of the slow-conducting isthmus.
atheter ablation. Four- or 8-mm-tip catheters (Biosense-
ebster) were used for RFA in 22 patients. Two patients had
blation performed with a 3.5-mm-tip open irrigated catheter.
uccessful RFA was defined as termination of SVT and
oninducibility by pacing. Atrioventricular valve isthmus abla-
ion on the right side involved creation of a bidirectional line of
lock between the tricuspid valve-inferior vena cava isthmus.
he ablation for left-sided isthmus-dependent flutter involved
reation of a line between the mitral annulus and the region of
he suture site close to the left inferior pulmonary vein (these
ines were not validated by pacing maneuvers). Sites of ablation
ere defined by electroanatomic mapping.
tatistics. The SAS software (version 9.1, SAS Institute,
ary, North Carolina) was used for all statistical analyses.
ach variable was checked for normality of distribution with
he Shapiro-Wilk test, although none required transforma-
ion. Values are presented as mean and SD for demographic
ariables. A 1-sample t test was used to compare clinical
ariables with standardized references based on published
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June 10, 2008:2241–9 Catheter Ablation in Post-Transplant Heartseans, SEMs, and SDs of healthy individuals (22,23).
values 0.05 were considered significant.
esults
F and AFL in stable OHT patients. Of the 729
atients, 152 (23.1%) had died by January 1, 2006, and 24
f these (3.3%) died in the immediate post-operative period.
orty-four patients transferred care to other medical centers
r were lost to follow-up. In the 657 adult patients who had
ot died in the post-operative period, the mean and median
ollow-up were 6.6 and 4.1 years, respectively. In 4,299
erson-years of follow-up, 46 patients (7.0%) presented
ith AF. Of these, 26 patients (4.0%) had AF in the
ost-operative period, 16 patients (2.4%) had AF associated
ith acute rejection, 3 (0.5%) patients had AF associated
ith severe transplant vasculopathy, and 1 patient had AF
ssociated with severe sepsis. In the absence of the afore-
entioned conditions, paroxysmal or chronic AF was not
ncountered (Fig. 1). In comparison, 60 patients (9.1%)
resented with documented AFL. Of these, 16 patients
2.4%) had AFL in the post-operative period, 17 (2.6%) had
FL associated with acute rejection, 2 (0.3%) with severe
asculopathy, 1 with infection, and 1 in the setting of
ulmonary emboli. Twenty-three stable patients presented
ith documented AFL without evidence of rejection or
asculopathy (Fig. 1). Therefore, the incidence of AFL not
ssociated with the aforementioned conditions (cardio-
erted, treated medically, or with catheter ablation) was
Figure 1 Incidence of Atrial Flutter Versus Atrial Fibrillation
In the cohort of cardiac transplant patients, the percentage of patients with any at
appropriate clinical setting are shown. Stable was defined as those without simult
immediate post-operative period while experiencing the arrhythmia as shown. Note
parison, atrial flutter occurred in 4.6% of patients and, in 2.3%, required electroph.5% during the same follow-up period. No patient was
eferred for ablation of AF, whereas 2.1% of the cohort (i.e.,
3% of those presenting with AFL) required EPS and
blation for successful treatment of their arrhythmias.
Patients with post-operative AF associated with allograft
ejection or vasculopathy were cardioverted, and the under-
ying rejection or vasculopathy was treated. Patients who
ere chemically cardioverted—either in the perioperative
eriod or after successful treatment of allograft rejection,
asculopathy, or infection—had their anti-arrhythmic drug
herapy discontinued within 3 months of discharge. None of
hese patients had recurrence of their arrhythmia during
ollow-up, unless in association with repeat acute rejection
r severe transplant vasculopathy.
RV analysis. In this cohort, 34 Holter recordings were
vailable for analysis. Of these, 4 were excluded secondary to
ultiple episodes of documented supraventricular and ven-
ricular arrhythmias. Of the remaining 30, HRV data were
vailable on 16 patients (10 men, 6 women, age 55  16
ears). The overall as well as the gender-based mean
DNN, SDANN, SDNN index, and RMSSD were com-
ared with healthy age- and gender-matched historical
ontrol subjects (Table 1). Compared with age- (40 to 60
ears) and gender-matched healthy adult references previ-
usly reported, SDNN, SDANN, and SDNN index were
ignificantly depressed (22–24). Furthermore, the depres-
ion of HRV parameters was in the moderate-to-severe
ange, when compared with adults with coronary artery
tter and fibrillation as well as the individual arrhythmias associated with the
s severe transplant vasculopathy, sepsis, or acute rejection who are not in the
o atrial fibrillation was observed in stable cardiac transplant patients. In com-
ical study and ablation. AFib  atrial fibrillation; Aflutter  atrial flutter.rial flu
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Catheter Ablation in Post-Transplant Hearts June 10, 2008:2241–9isease thought to be at high risk of sudden cardiac death
i.e., SDNN 50 for severely and SDNN 100 for mod-
rately depressed) (24). This provides evidence supporting
utonomic denervation in OHT patients.
ncidence of SVT in a stable heart transplant cohort. Of
he 729 patients, we identified 47 adult OHT patients with
aroxysmal, persistent, or chronic SVT (7.1%) who were
ot in the immediate post-operative period and whose
rrhythmia was not complicated by acute rejection, vascu-
opathy, or sepsis. No patient presented with AF. Atrial
utter was the most common arrhythmia identified in the
verall cohort, with 23 of 47 patients having documented
FL. Of the 47 patients with SVT, 24 (49%) had SVT
efractory to medical therapy and required EPS and ablation
or treatment, whereas the remaining patients were success-
ully treated either with medical therapy or cardioversion.
he summary of mechanism of the arrhythmias found in
he group referred to EPS is shown in Figure 2. Fourteen
58%) presented with palpitations, 7 (29%) with symptoms
f heart failure (i.e., fatigue, shortness of breath, paroxysmal
octurnal dyspnea, edema), and 3 (13%) were asymptom-
tic. Patient characteristics are listed in Table 2.
rrhythmias documented during EPS. Of the 47 stable
atients with SVT, 24 underwent EPS and ablation. The
echanism of arrhythmias noted in these patients were:
sthmus-dependent right or left AFL (n  14); macro-
eentrant intra-atrial tachycardia (n  7; left atrial  1,
ight atrial  6); accessory pathway mediated tachycardia:
eart Rate Variability Parameters
Table 1 Heart Rate Variability Parameters
OHT Patients Control Subjects
Overall
Age (yrs) 55 15 50–59
Heart rate (beats/min) 95 11* 76 9
SDNN (ms) 47 13* 121 27
SDANN (ms) 41 14* 106 27
SDNN index (ms) 16 11* 52 15
RMSSD (ms) 19 13 25 9
Men
Age (yrs) 63 11 50–69
Heart rate (beats/min) 95 11* 78 11
SDNN (ms) 40 11* 117 30
SDANN (ms) 35 12* 104 28
SDNN index (ms) 14 11* 46 18
RMSSD (ms) 16 13 22 8
Women
Age (yrs) 43 14 30–49
Heart rate (beats/min) 86 12 79 7
SDNN (ms) 58 9* 129 30
SDANN (ms) 53 9* 114 31
SDNN index (ms) 19 10.3* 58 13
RMSSD (ms) 23 14 31 10
ll parameters are given as mean  SD. *Significantly depressed, p  0.05, parameters in
rthotopic heart transplant (OHT) patients compared with the healthy reference population.
RMSSD  root-mean-square of successive normal sinus RR interval difference; SDANN  SD of
he averaged normal sinus RR intervals for all 5-min segments; SDNN SD of all normal sinus RR
ntervals over 24 h; SVT  supraventricular tachycardia.trioventricular reentry (AVRT) (n  2); and atrioventric-
A
dlar nodal reentrant tachycardia (AVNRT) (n  1) (Table
, Fig. 2). Of note, 1 patient had 2 right atrial tachycardias
nd 1 left atrial tachycardia documented at the time of EPS.
ersistent or paroxysmal AF was not identified in any stable
ost-transplant patient.
VNRT. One patient with AVNRT had recurrent palpi-
ations and poor response to beta-blockers. Electrophysio-
ogical study confirmed AVNRT. Radiofrequency modifi-
ation of the slow atrioventricular nodal pathway was
urative.
VRT. Two patients had clinical tachycardia with AVRT
s the underlying mechanism. There were no baseline
lectrocardiograms available from the donor hearts before
Figure 2 Classification of SVT in Stable OHT Patients
Incidence of the different types of drug refractory supraventricular tachycardia
(SVT) in this cohort of orthotopic heart transplant (OHT) patients who under-
went electrophysiological study (EPS) is shown. Note that isthmus-dependent
atrial flutter was the most commonly observed SVT, followed by scar-related
macro-reentrant tachycardia. AT  atrial tachycardia; AVNRT  atrioventricular
nodal reentrant tachycardia; AVRT  atrioventricular reentrant tachycardia.
atient Characteristicsf Stable OHT Pat ent Referred for EPS
Table 2 Patient Characteristicsof Stable OHT Patients Referred for EPS
Number of patients undergoing EPS 24
Mean age (yrs) 48 18
Male 13
Female 11
Ejection fraction (%) 56 7
Type of anastomoses
Biatrial 10
Bicaval 14
Electrophysiological mechanisms
Atrial flutter 15
Macro-reentry
Atrial tachycardia 6
AVNRT 1
AVRT 2
Catheter ablation
Effective 23
Repeat procedures 3VNRT atrioventricular nodal reentrant tachycardia; AVRT atrioventricular reentrant tachycar-
ia; EPS  electrophysiological study; OHT  orthotopic heart transplant.
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June 10, 2008:2241–9 Catheter Ablation in Post-Transplant Heartsransplantation. The EPS confirmed their diagnoses, with 1
eft-sided accessory pathway arising from the inferior aspect
f the mitral annulus, requiring transseptal puncture for
blation, and 1 right-sided accessory pathway that was
iagnosed after ablation of AFL in the same patient.
adiofrequency ablation was curative in both cases.
T. Six patients were identified as having scar-related right
trial reentrant tachycardia with electroanatomical mapping.
n all 6 cases, the reentrant circuit was identified at the
pper right atrium, around the native and donor anasto-
otic suture line. Ablation along the suture line was
urative in our patients. One of these patients had 2 right
trial and 1 left atrial tachycardias. The focus of 1 of the
car-related macro-reentrant right atrial tachycardias was
uccessfully ablated with a plan to perform a second ablation
f symptoms recurred. However, no further episodes of
achycardia were noted after the first ablation. A second
atient had macro-reentrant tachycardia in his native right
trium with breakthrough conduction into the donor heart.
he RFA was also curative. One patient had macro-
eentrant left atrial tachycardia around the donor left atrial
uff. The RFA at the slow conduction site of the reentrant
ircuit resulted in a cure of the tachycardia (Fig. 3).
sthmus-dependent AFL. A total of 14 patients were
dentified as having isthmus-dependent AFL as the under-
ying mechanism of their SVT. Six occurred in patients with
Figure 3 Left Atrial Macro-Reentrant Tachycardia
(A) Surface electrocardiogram demonstrates atrial tachycardia at a rate of 150 be
atrium (LA), just anterior to the left superior pulmonary vein (LSPV), involving the d
tion lesions. (C) Fluoroscopic left anterior oblique view: this tachycardia was mapp
nary sinus; LAT  left atrial tachycardia; LIPV  left inferior pulmonary vein; RA i-atrial anastomosis, and 8 occurred in patients with bicaval
nastomosis. In 12 patients the reentrant circuits were
ricuspid isthmus-dependent, and in 2 patients the reentrant
ircuits were in the left atrium around the mitral annulus, as
onfirmed by electroanatomic and entrainment mapping
Figs. 4 and 5). Regardless of the type of anastomosis, 12 of
he 14 patients had tricuspid isthmus-dependent AFL. One
atient with bi-atrial anastomosis had incessant AFL of the
ative right atrium with variable conduction to the grafted
trium. In the EP laboratory, the flutter was found to use 2
ocal sites at the proximal and distal anastomosis for
onduction into the graft atrium, which became 1:1 with
soproterenol infusion. Ablation at these 2 focal sites termi-
ated the tachycardia. Although RFA was effective in all of
hese patients, 2 patients had a recurrent tachycardia (re-
urrent right AFL and right atrial macro-reentrant tachy-
ardia), requiring a second EPS and ablation. One patient
ad associated left ventricular dysfunction with a decrease in
jection fraction from 50% to 55% at baseline to 30% to
5%. This subsequently improved after ablation of AFL.
iscussion
ajor findings. This is the largest published study to date
n the mechanism of arrhythmias in patients who have
ndergone heart transplantation. Atrial flutter was the most
in. (B) Activation maps demonstrate the tachycardia using an isthmus in the left
but not native (gray) left atrium (LA cuff tachycardia). Red marks represent abla-
d ablated with transseptal catheterization. ABL  ablation catheter; CS  coro-
trium; SCR  native atrium tagged as “scar” and shown in gray.ats/m
onor,
ed an
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Catheter Ablation in Post-Transplant Hearts June 10, 2008:2241–9ommon arrhythmia identified, regardless of clinical setting.
o cases of paroxysmal or chronic AF were seen in our
ohort of transplant patients in the absence of vasculopathy,
ejection, severe infection, or the acute post-operative pe-
iod. Supraventricular tachycardia occurred in 47 stable
atients (7.1%) and required an EPS and catheter ablation
n 24 patients (3.7%). The most common mechanism of
rrhythmia in stable patients was isthmus-dependent AFL
58%) followed by scar-related AT (29%).
F. Atrial fibrillation in the transplant population is highly
ebated both in terms of onset and maintenance. Our
urrent report suggests persistent AF is extremely rare in
table OHT patients. Three broad mechanisms have been
ssociated with the initiation and maintenance of AF:
) rapidly discharging triggers or foci, especially from the
horacic veins; 2) the autonomic nervous system, which
ight promote electrophysiological heterogeneity; and
) substrate abnormalities promoting wavelet reentry. Inter-
stingly, cardiac transplant patients by definition have com-
lete surgical isolation of their pulmonary veins. Further-
ore, they essentially lack cardiac innervation, which was
urther corroborated by HRV data in our population show-
ng significantly depressed parameters. This supports both
he autonomic and/or the pulmonary vein trigger hypothesis
or genesis of AF. Transient episodes of AF have been reported
n OHT patients in the immediate post-surgical period who
ere on vasopressors and had an altered hemodynamic and
eurohormonal state. These episodes were also observed in our
Figure 4 Atrio-Atrial Anastomosis With Donor Isthmus Right At
(A) Fluoroscopic right anterior oblique view shows the position of the duodecapola
proximal electrode (D10) along the superior aspect of the interatrial septum. (B) E
sue). The flutter wave-front involves the donor atrium only and is propagating in a
sequence in the donor atrium confirms counterclockwise activation. A critical isthm
sociated atrial rhythm (D6 to D9) and did not conduct to the donor atrium. Therefo
D10  duodecapolar bipoles 1 to 10; DDC  duodecapolar catheter; LV  left veohort of 729 patients. However, once cardioverted, these hatients were not at an increased risk of developing persistent
r chronic AF during follow-up. Furthermore, compared with
istorical control subjects in whom the incidence of post-
perative AF ranges from 20% to 50% (19,25,26), the inci-
ence of post-operative AF was extremely low (4%) in our
HT population, suggesting that heart transplantation with
ts denervation and pulmonary isolation might have a protec-
ive role in preventing post-operative AF.
Substrate abnormalities, such as myocarditis, abnormal he-
odynamic status, and inflammation, can cause direct electro-
hysiological alteration of the atrial myocardium, atrial stretch,
nd interstitial fibrosis, permitting and promoting wavelet
eentry. A prior study performed at our institution reported
hat patients experienced episodes of AF long after their
ransplants, but these episodes were associated with rejection or
schemia related to severe transplant vasculopathy, altering the
ormal atrial substrate (10).
It has been suggested that long-term cardiac transplant
ecipients develop sympathetic and parasympathetic reinnerva-
ion (27,28). It is well known that vagal tone and acetylcholine
horten activation recovery intervals, potentially playing a role
n the genesis of AF (29,30). Atrial fibrillation in stable OHT
atients has also been reported in 3 cases. Although the
echanism of the underlying AF in these reports was unclear,
ll 3 patients were affected 5 to 10 years after transplantation,
uggesting a role for parasympathetic reinnervation (20). Fur-
hermore, all were successfully cardioverted without recurrence.
Transplantation could also potentially reduce the likeli-
lutter and Dissociated Native Atrial Rhythm
eter with the distal bipoles (D1 to D3) along the tricuspid valve isthmus and the
anatomic maps of atrio-atrial anastomosis (gray areas identify native atrial tis-
rclockwise fashion along the tricuspid annulus. (C) Intracardiac activation
s located near D5 in the lateral right atrium wall. The native atrium was in a dis-
lation of the native atrium was not performed. CS  coronary sinus; D1 to
; RV  right ventricle.rial F
r cath
lectro
counte
us wa
re, ab
ntricleood of AF by resulting in a reduction of the “critical mass”
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June 10, 2008:2241–9 Catheter Ablation in Post-Transplant Heartsf atrial myocardium required for the maintenance of the
rrhythmia (31,32).
VRT AND AVNRT AFTER TRANSPLANTATION. Although
dult cases involving accessory pathways in post-OHT
atients have been documented in published reports (3–5),
nly 2 cases reported a donor arrhythmia on electrocardi-
graphy, 1 SVT and another unspecified. In the remaining
ases, as in our 2 patients, there was no prior knowledge of
re-excitation in the donor heart, on the basis of the
re-operative electrocardiography. Furthermore, although
ore than one-half of the reported cases required ablation
ithin 1 month, RFA was curative in all cases.
Cases of AVNRT reported in post-OHT patients are
are (1,2,5). Once again, RFA with slow pathway modifi-
ation was effective at treating AVNRT in all cases.
CAR-RELATED AT. Surgical scars at atrial suture lines can
reate areas of slowed conduction predisposing to atrial
achycardia (33). This in part prompted the development of
icaval anastomosis, which is now a more widely used
echnique for OHT, resulting in a significant reduction of
Figure 5 LA (LIPV-Mitral Isthmus) Flutter
(A) Activation map: the flutter circuit begins in the inferior wall of the LA (pink) clo
annulus as well as around and over the mitral annulus. The ablation line, shown,
scopic left anterior oblique view: an ablation catheter was placed in the LA and du
the activation map in panel A showing the earliest activation in the LA and extend
SVC  superior vena cava; other abbreviations as in Figure 3.trial arrhythmias after OHT (33,34). In our study 6 of the tATs ablated—5 in right atrium and 1 in left atrium—were
elated to scar formation with the reentrant circuit involving
he isthmuses created by surgical suture lines. Electroana-
omic mapping helped to determine the boundary and
ircuit in these tachycardias. Entrainment mapping was
erformed to identify critical isthmuses and successful
blation.
TRIOVENTRICULAR VALVE ISTHMUS-DEPENDENT TACHY-
ARDIA. Atrial flutter can be encountered in OHT patients
n the immediate post-transplant period and during acute
ejection; it has been shown that patients with acute
ejection and severe transplant vasculopathy have lower left
entricular ejection fractions, increased left ventricular end-
iastolic pressures, right atrial enlargement, and decreased
ricuspid valve deceleration times, potentially contributing
o the initiation and persistence of atrial arrhythmias
10,11). However, both clockwise and counterclockwise
FL also occur in post-transplant patients without symp-
oms and signs of acute rejection and normal left ventricular
unction (14–18). Bicaval anastomosis essentially preserves
the CS3-4 bipole and propagates across to the RA and around the tricuspid
sfully terminated the arrhythmia without recurrence during follow-up. (B) Fluoro-
polar catheter in the RA for mapping. (C) Intracardiac tracings corresponding to
the RA. LAA  left atrial appendage; RSPV  right superior pulmonary vein;se to
succes
odeca
ing tohe integrity of the right atrium and avoids the formation of
r
g
f
p
t
n
n
o
m
p
A
t
p
i
p
o
r
S
e
c
t
d
u
m
w
m
C
T
a
c
c
t
v
p
c
t
c
p
v
p
F
a
m
i
R
U
D
M
C
R
1
1
1
1
1
1
1
1
1
1
2
2
2248 Vaseghi et al. JACC Vol. 51, No. 23, 2008
Catheter Ablation in Post-Transplant Hearts June 10, 2008:2241–9ight atrial scars, placing them instead in areas with negli-
ible arrhythmogenicity (34). It has been suggested, there-
ore, that bicaval anastomosis reduces the risk of AFL
ost-transplantation when compared with atrio-atrial anas-
omosis (33). However, in our study, although this tech-
ique prevented reentry around the right atrial scar, it did
ot prevent tricuspid isthmus-dependent typical AFL from
ccurring. In fact, tricuspid isthmus-dependent AFL was the
ost common type of flutter, similar to nontransplanted
atients. Eight of 14 patients with tricuspid-dependent
FL in our study had bicaval anastomoses. This is the first
ime this type of flutter has been reported in this group of
atients. Given the size of our study, the prevalence of AFL
n these patients in comparison with the general OHT
opulation cannot be determined. However, the incidence
f flutter in this transplanted population stayed the same
egardless of the type of anastomosis.
tudy limitations. Despite extensive review of patient charts,
lectronic documents, 24-h Holter monitors, echocardiograms,
ardiac catheterizations, and electrocardiograms, it is possible
hat certain paroxysmal episodes of arrhythmia were not
ocumented, and thus the incidence of arrhythmias depicted
nderestimates their impact. However, given regular and close
onitoring of all of our cardiac transplant patients, we believe
e have captured the large majority of the burden of arrhyth-
ias requiring any form of intervention or treatment.
onclusions
his is the largest study to date reporting the incidence and
ssociated clinical setting of AFL and AF in a cohort of 729
ardiac transplant patients. Atrial flutter was the most
ommon arrhythmia observed, regardless of clinical condi-
ion. Atrial fibrillation was seen in patients with severe
asculopathy, acute rejection, sepsis, or in the post-operative
eriod. However, paroxysmal or chronic AF was not en-
ountered in stable transplant patients, suggesting the exis-
ence of different mechanisms for AF under specific clinical
onditions. This study also confirms earlier findings that
re-existing substrates (accessory pathways and dual atrio-
entricular nodal physiology) can cause SVT in the trans-
lanted heart and can be treated effectively by RFA.
urthermore, surgical scars are central to AT and can cause
rrhythmias in the transplanted heart. Bicaval anastomosis
ight reduce scar-related AT, but atrioventricular valve
sthmus-dependent AFL can still occur in these patients.
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